[1]
Y. Matsumoto, T. Fukumoto, W. Takahashi, and C. Nishigori, “Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma”, Dermatol Reports, vol. 15, no. 2, Dec. 2022.